TY - JOUR
T1 - Distinction among eight opiate drugs in urine by gas chromatography-mass spectrometry
AU - Nowatzke, William
AU - Zeng, Jianbo
AU - Saunders, Al
AU - Bohrer, Alan
AU - Koenig, John
AU - Turk, John
N1 - Funding Information:
We thank Mary E. Mitchell and Doug Dalrymple for technical assistance. This work was supported in part by a grant to the Washington University Mass Spectrometry Resource from the National Institutes of Health (P41-RR-00954).
PY - 1999/9
Y1 - 1999/9
N2 - Opiates are commonly abused substances, and forensic urine drug-testing for them requires gas chromatographic-mass spectrometric (GC-MS) confirmation. There are also medical reasons to test urine for opiates, and confirmation procedures other than GC-MS are often used for medical drug-testing. A thin-layer chromatographic (TLC) method distinguishes morphine, acetylmorphine, hydromorphone, oxymorphone, codeine, dihydrocodeine, hydrocodone, and oxycodone in clinical specimens. In certain clinical circumstances, GC-MS confirmation is requested for opiates identified by TLC, but, to our knowledge, no previous report examines all of the above opiates in a single GC-MS procedure. We find that they can be distinguished by GC-MS analyses of trimethylsilyl (TMS) ether derivatives, and identities of 6-keto opiates can be further confirmed by GC-MS analysis of methoxime (MO)-TMS derivatives. Inclusion of deuterium-labeled internal standards permits identification of the opiates in urine at concentrations below the TLC cutoff level of 600 ng/ml, and the GC-MS assay is linear over a concentration range that spans that level. This GC-MS procedure has proved useful as a third-stage identification step in a medical drug-testing sequence involving prior immunoassay and TLC. Copyright (C) 1999 Elsevier Science B.V.
AB - Opiates are commonly abused substances, and forensic urine drug-testing for them requires gas chromatographic-mass spectrometric (GC-MS) confirmation. There are also medical reasons to test urine for opiates, and confirmation procedures other than GC-MS are often used for medical drug-testing. A thin-layer chromatographic (TLC) method distinguishes morphine, acetylmorphine, hydromorphone, oxymorphone, codeine, dihydrocodeine, hydrocodone, and oxycodone in clinical specimens. In certain clinical circumstances, GC-MS confirmation is requested for opiates identified by TLC, but, to our knowledge, no previous report examines all of the above opiates in a single GC-MS procedure. We find that they can be distinguished by GC-MS analyses of trimethylsilyl (TMS) ether derivatives, and identities of 6-keto opiates can be further confirmed by GC-MS analysis of methoxime (MO)-TMS derivatives. Inclusion of deuterium-labeled internal standards permits identification of the opiates in urine at concentrations below the TLC cutoff level of 600 ng/ml, and the GC-MS assay is linear over a concentration range that spans that level. This GC-MS procedure has proved useful as a third-stage identification step in a medical drug-testing sequence involving prior immunoassay and TLC. Copyright (C) 1999 Elsevier Science B.V.
KW - Acetylmorphine
KW - Codeine
KW - Dihydrocodeine
KW - Hydrocodone
KW - Hydromorphone
KW - Medical drug-testing
KW - Morphine
KW - Oxycodone
KW - Oxymorphone
UR - http://www.scopus.com/inward/record.url?scp=0032774002&partnerID=8YFLogxK
U2 - 10.1016/S0731-7085(99)00086-2
DO - 10.1016/S0731-7085(99)00086-2
M3 - Article
C2 - 10701990
AN - SCOPUS:0032774002
VL - 20
SP - 815
EP - 828
JO - Journal of Pharmaceutical and Biomedical Analysis
JF - Journal of Pharmaceutical and Biomedical Analysis
SN - 0731-7085
IS - 5
ER -